Global DPP-4 Inhibitor Hypoglycemic Drugs Supply, Demand and Key Producers, 2023-2029
The global DPP-4 Inhibitor Hypoglycemic Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
DPP-4 inhibitor hypoglycemic drugs can not only reduce the blood sugar concentration of patients, but also promote insulin secretion, and even repair damaged islet cells. Compared with traditional hypoglycemic drugs, they have many advantages such as high efficacy and low side effects.
This report studies the global DPP-4 Inhibitor Hypoglycemic Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for DPP-4 Inhibitor Hypoglycemic Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of DPP-4 Inhibitor Hypoglycemic Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global DPP-4 Inhibitor Hypoglycemic Drugs total production and demand, 2018-2029, (K Units)
Global DPP-4 Inhibitor Hypoglycemic Drugs total production value, 2018-2029, (USD Million)
Global DPP-4 Inhibitor Hypoglycemic Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global DPP-4 Inhibitor Hypoglycemic Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: DPP-4 Inhibitor Hypoglycemic Drugs domestic production, consumption, key domestic manufacturers and share
Global DPP-4 Inhibitor Hypoglycemic Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global DPP-4 Inhibitor Hypoglycemic Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global DPP-4 Inhibitor Hypoglycemic Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global DPP-4 Inhibitor Hypoglycemic Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, MSD Pharma, Novartis, AstraZeneca Pharmaceuticals, Takeda Pharmaceutical, Boehringer Ingelheim International, Huahai Pharmaceutical, Langnuo Pharmaceutical and QILU Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World DPP-4 Inhibitor Hypoglycemic Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global DPP-4 Inhibitor Hypoglycemic Drugs Market, By Region:
1. How big is the global DPP-4 Inhibitor Hypoglycemic Drugs market?
2. What is the demand of the global DPP-4 Inhibitor Hypoglycemic Drugs market?
3. What is the year over year growth of the global DPP-4 Inhibitor Hypoglycemic Drugs market?
4. What is the production and production value of the global DPP-4 Inhibitor Hypoglycemic Drugs market?
5. Who are the key producers in the global DPP-4 Inhibitor Hypoglycemic Drugs market?
6. What are the growth factors driving the market demand?
DPP-4 inhibitor hypoglycemic drugs can not only reduce the blood sugar concentration of patients, but also promote insulin secretion, and even repair damaged islet cells. Compared with traditional hypoglycemic drugs, they have many advantages such as high efficacy and low side effects.
This report studies the global DPP-4 Inhibitor Hypoglycemic Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for DPP-4 Inhibitor Hypoglycemic Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of DPP-4 Inhibitor Hypoglycemic Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global DPP-4 Inhibitor Hypoglycemic Drugs total production and demand, 2018-2029, (K Units)
Global DPP-4 Inhibitor Hypoglycemic Drugs total production value, 2018-2029, (USD Million)
Global DPP-4 Inhibitor Hypoglycemic Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global DPP-4 Inhibitor Hypoglycemic Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: DPP-4 Inhibitor Hypoglycemic Drugs domestic production, consumption, key domestic manufacturers and share
Global DPP-4 Inhibitor Hypoglycemic Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global DPP-4 Inhibitor Hypoglycemic Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global DPP-4 Inhibitor Hypoglycemic Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global DPP-4 Inhibitor Hypoglycemic Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, MSD Pharma, Novartis, AstraZeneca Pharmaceuticals, Takeda Pharmaceutical, Boehringer Ingelheim International, Huahai Pharmaceutical, Langnuo Pharmaceutical and QILU Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World DPP-4 Inhibitor Hypoglycemic Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global DPP-4 Inhibitor Hypoglycemic Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Sitagliptin
- Vildagliptin
- Saxagliptin
- Alogliptin
- Linagliptin
- Others
- Hospital
- Clinic
- Merck
- MSD Pharma
- Novartis
- AstraZeneca Pharmaceuticals
- Takeda Pharmaceutical
- Boehringer Ingelheim International
- Huahai Pharmaceutical
- Langnuo Pharmaceutical
- QILU Pharmaceutical
- Chia Tai-Tianqing Pharmaceutical
- Gan & Lee Pharmaceuticals
- Kelun Pharmaceutical
- YOKO Pharmaceutical
- Disainuo Pharmaceutical
- Reyoung Pharmaceutical
1. How big is the global DPP-4 Inhibitor Hypoglycemic Drugs market?
2. What is the demand of the global DPP-4 Inhibitor Hypoglycemic Drugs market?
3. What is the year over year growth of the global DPP-4 Inhibitor Hypoglycemic Drugs market?
4. What is the production and production value of the global DPP-4 Inhibitor Hypoglycemic Drugs market?
5. Who are the key producers in the global DPP-4 Inhibitor Hypoglycemic Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 DPP-4 Inhibitor Hypoglycemic Drugs Introduction
1.2 World DPP-4 Inhibitor Hypoglycemic Drugs Supply & Forecast
1.2.1 World DPP-4 Inhibitor Hypoglycemic Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2029)
1.2.3 World DPP-4 Inhibitor Hypoglycemic Drugs Pricing Trends (2018-2029)
1.3 World DPP-4 Inhibitor Hypoglycemic Drugs Production by Region (Based on Production Site)
1.3.1 World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Region (2018-2029)
1.3.2 World DPP-4 Inhibitor Hypoglycemic Drugs Production by Region (2018-2029)
1.3.3 World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Region (2018-2029)
1.3.4 North America DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2029)
1.3.5 Europe DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2029)
1.3.6 China DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2029)
1.3.7 Japan DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 DPP-4 Inhibitor Hypoglycemic Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 DPP-4 Inhibitor Hypoglycemic Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World DPP-4 Inhibitor Hypoglycemic Drugs Demand (2018-2029)
2.2 World DPP-4 Inhibitor Hypoglycemic Drugs Consumption by Region
2.2.1 World DPP-4 Inhibitor Hypoglycemic Drugs Consumption by Region (2018-2023)
2.2.2 World DPP-4 Inhibitor Hypoglycemic Drugs Consumption Forecast by Region (2024-2029)
2.3 United States DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029)
2.4 China DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029)
2.5 Europe DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029)
2.6 Japan DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029)
2.7 South Korea DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029)
2.8 ASEAN DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029)
2.9 India DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029)
3 WORLD DPP-4 INHIBITOR HYPOGLYCEMIC DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Manufacturer (2018-2023)
3.2 World DPP-4 Inhibitor Hypoglycemic Drugs Production by Manufacturer (2018-2023)
3.3 World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Manufacturer (2018-2023)
3.4 DPP-4 Inhibitor Hypoglycemic Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global DPP-4 Inhibitor Hypoglycemic Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for DPP-4 Inhibitor Hypoglycemic Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for DPP-4 Inhibitor Hypoglycemic Drugs in 2022
3.6 DPP-4 Inhibitor Hypoglycemic Drugs Market: Overall Company Footprint Analysis
3.6.1 DPP-4 Inhibitor Hypoglycemic Drugs Market: Region Footprint
3.6.2 DPP-4 Inhibitor Hypoglycemic Drugs Market: Company Product Type Footprint
3.6.3 DPP-4 Inhibitor Hypoglycemic Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Production Value Comparison
4.1.1 United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Production Comparison
4.2.1 United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Consumption Comparison
4.3.1 United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based DPP-4 Inhibitor Hypoglycemic Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based DPP-4 Inhibitor Hypoglycemic Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2023)
4.5 China Based DPP-4 Inhibitor Hypoglycemic Drugs Manufacturers and Market Share
4.5.1 China Based DPP-4 Inhibitor Hypoglycemic Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2023)
4.6 Rest of World Based DPP-4 Inhibitor Hypoglycemic Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based DPP-4 Inhibitor Hypoglycemic Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World DPP-4 Inhibitor Hypoglycemic Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Sitagliptin
5.2.2 Vildagliptin
5.2.3 Saxagliptin
5.2.4 Alogliptin
5.2.5 Linagliptin
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World DPP-4 Inhibitor Hypoglycemic Drugs Production by Type (2018-2029)
5.3.2 World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Type (2018-2029)
5.3.3 World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World DPP-4 Inhibitor Hypoglycemic Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World DPP-4 Inhibitor Hypoglycemic Drugs Production by Application (2018-2029)
6.3.2 World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Application (2018-2029)
6.3.3 World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.1.4 Merck DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 MSD Pharma
7.2.1 MSD Pharma Details
7.2.2 MSD Pharma Major Business
7.2.3 MSD Pharma DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.2.4 MSD Pharma DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 MSD Pharma Recent Developments/Updates
7.2.6 MSD Pharma Competitive Strengths & Weaknesses
7.3 Novartis
7.3.1 Novartis Details
7.3.2 Novartis Major Business
7.3.3 Novartis DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.3.4 Novartis DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Novartis Recent Developments/Updates
7.3.6 Novartis Competitive Strengths & Weaknesses
7.4 AstraZeneca Pharmaceuticals
7.4.1 AstraZeneca Pharmaceuticals Details
7.4.2 AstraZeneca Pharmaceuticals Major Business
7.4.3 AstraZeneca Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.4.4 AstraZeneca Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 AstraZeneca Pharmaceuticals Recent Developments/Updates
7.4.6 AstraZeneca Pharmaceuticals Competitive Strengths & Weaknesses
7.5 Takeda Pharmaceutical
7.5.1 Takeda Pharmaceutical Details
7.5.2 Takeda Pharmaceutical Major Business
7.5.3 Takeda Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.5.4 Takeda Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Takeda Pharmaceutical Recent Developments/Updates
7.5.6 Takeda Pharmaceutical Competitive Strengths & Weaknesses
7.6 Boehringer Ingelheim International
7.6.1 Boehringer Ingelheim International Details
7.6.2 Boehringer Ingelheim International Major Business
7.6.3 Boehringer Ingelheim International DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.6.4 Boehringer Ingelheim International DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Boehringer Ingelheim International Recent Developments/Updates
7.6.6 Boehringer Ingelheim International Competitive Strengths & Weaknesses
7.7 Huahai Pharmaceutical
7.7.1 Huahai Pharmaceutical Details
7.7.2 Huahai Pharmaceutical Major Business
7.7.3 Huahai Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.7.4 Huahai Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Huahai Pharmaceutical Recent Developments/Updates
7.7.6 Huahai Pharmaceutical Competitive Strengths & Weaknesses
7.8 Langnuo Pharmaceutical
7.8.1 Langnuo Pharmaceutical Details
7.8.2 Langnuo Pharmaceutical Major Business
7.8.3 Langnuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.8.4 Langnuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Langnuo Pharmaceutical Recent Developments/Updates
7.8.6 Langnuo Pharmaceutical Competitive Strengths & Weaknesses
7.9 QILU Pharmaceutical
7.9.1 QILU Pharmaceutical Details
7.9.2 QILU Pharmaceutical Major Business
7.9.3 QILU Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.9.4 QILU Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 QILU Pharmaceutical Recent Developments/Updates
7.9.6 QILU Pharmaceutical Competitive Strengths & Weaknesses
7.10 Chia Tai-Tianqing Pharmaceutical
7.10.1 Chia Tai-Tianqing Pharmaceutical Details
7.10.2 Chia Tai-Tianqing Pharmaceutical Major Business
7.10.3 Chia Tai-Tianqing Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.10.4 Chia Tai-Tianqing Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
7.10.6 Chia Tai-Tianqing Pharmaceutical Competitive Strengths & Weaknesses
7.11 Gan & Lee Pharmaceuticals
7.11.1 Gan & Lee Pharmaceuticals Details
7.11.2 Gan & Lee Pharmaceuticals Major Business
7.11.3 Gan & Lee Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.11.4 Gan & Lee Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Gan & Lee Pharmaceuticals Recent Developments/Updates
7.11.6 Gan & Lee Pharmaceuticals Competitive Strengths & Weaknesses
7.12 Kelun Pharmaceutical
7.12.1 Kelun Pharmaceutical Details
7.12.2 Kelun Pharmaceutical Major Business
7.12.3 Kelun Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.12.4 Kelun Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Kelun Pharmaceutical Recent Developments/Updates
7.12.6 Kelun Pharmaceutical Competitive Strengths & Weaknesses
7.13 YOKO Pharmaceutical
7.13.1 YOKO Pharmaceutical Details
7.13.2 YOKO Pharmaceutical Major Business
7.13.3 YOKO Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.13.4 YOKO Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 YOKO Pharmaceutical Recent Developments/Updates
7.13.6 YOKO Pharmaceutical Competitive Strengths & Weaknesses
7.14 Disainuo Pharmaceutical
7.14.1 Disainuo Pharmaceutical Details
7.14.2 Disainuo Pharmaceutical Major Business
7.14.3 Disainuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.14.4 Disainuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Disainuo Pharmaceutical Recent Developments/Updates
7.14.6 Disainuo Pharmaceutical Competitive Strengths & Weaknesses
7.15 Reyoung Pharmaceutical
7.15.1 Reyoung Pharmaceutical Details
7.15.2 Reyoung Pharmaceutical Major Business
7.15.3 Reyoung Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.15.4 Reyoung Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Reyoung Pharmaceutical Recent Developments/Updates
7.15.6 Reyoung Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 DPP-4 Inhibitor Hypoglycemic Drugs Industry Chain
8.2 DPP-4 Inhibitor Hypoglycemic Drugs Upstream Analysis
8.2.1 DPP-4 Inhibitor Hypoglycemic Drugs Core Raw Materials
8.2.2 Main Manufacturers of DPP-4 Inhibitor Hypoglycemic Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 DPP-4 Inhibitor Hypoglycemic Drugs Production Mode
8.6 DPP-4 Inhibitor Hypoglycemic Drugs Procurement Model
8.7 DPP-4 Inhibitor Hypoglycemic Drugs Industry Sales Model and Sales Channels
8.7.1 DPP-4 Inhibitor Hypoglycemic Drugs Sales Model
8.7.2 DPP-4 Inhibitor Hypoglycemic Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 DPP-4 Inhibitor Hypoglycemic Drugs Introduction
1.2 World DPP-4 Inhibitor Hypoglycemic Drugs Supply & Forecast
1.2.1 World DPP-4 Inhibitor Hypoglycemic Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2029)
1.2.3 World DPP-4 Inhibitor Hypoglycemic Drugs Pricing Trends (2018-2029)
1.3 World DPP-4 Inhibitor Hypoglycemic Drugs Production by Region (Based on Production Site)
1.3.1 World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Region (2018-2029)
1.3.2 World DPP-4 Inhibitor Hypoglycemic Drugs Production by Region (2018-2029)
1.3.3 World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Region (2018-2029)
1.3.4 North America DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2029)
1.3.5 Europe DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2029)
1.3.6 China DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2029)
1.3.7 Japan DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 DPP-4 Inhibitor Hypoglycemic Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 DPP-4 Inhibitor Hypoglycemic Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World DPP-4 Inhibitor Hypoglycemic Drugs Demand (2018-2029)
2.2 World DPP-4 Inhibitor Hypoglycemic Drugs Consumption by Region
2.2.1 World DPP-4 Inhibitor Hypoglycemic Drugs Consumption by Region (2018-2023)
2.2.2 World DPP-4 Inhibitor Hypoglycemic Drugs Consumption Forecast by Region (2024-2029)
2.3 United States DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029)
2.4 China DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029)
2.5 Europe DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029)
2.6 Japan DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029)
2.7 South Korea DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029)
2.8 ASEAN DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029)
2.9 India DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029)
3 WORLD DPP-4 INHIBITOR HYPOGLYCEMIC DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Manufacturer (2018-2023)
3.2 World DPP-4 Inhibitor Hypoglycemic Drugs Production by Manufacturer (2018-2023)
3.3 World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Manufacturer (2018-2023)
3.4 DPP-4 Inhibitor Hypoglycemic Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global DPP-4 Inhibitor Hypoglycemic Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for DPP-4 Inhibitor Hypoglycemic Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for DPP-4 Inhibitor Hypoglycemic Drugs in 2022
3.6 DPP-4 Inhibitor Hypoglycemic Drugs Market: Overall Company Footprint Analysis
3.6.1 DPP-4 Inhibitor Hypoglycemic Drugs Market: Region Footprint
3.6.2 DPP-4 Inhibitor Hypoglycemic Drugs Market: Company Product Type Footprint
3.6.3 DPP-4 Inhibitor Hypoglycemic Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Production Value Comparison
4.1.1 United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Production Comparison
4.2.1 United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Consumption Comparison
4.3.1 United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based DPP-4 Inhibitor Hypoglycemic Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based DPP-4 Inhibitor Hypoglycemic Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2023)
4.5 China Based DPP-4 Inhibitor Hypoglycemic Drugs Manufacturers and Market Share
4.5.1 China Based DPP-4 Inhibitor Hypoglycemic Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2023)
4.6 Rest of World Based DPP-4 Inhibitor Hypoglycemic Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based DPP-4 Inhibitor Hypoglycemic Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World DPP-4 Inhibitor Hypoglycemic Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Sitagliptin
5.2.2 Vildagliptin
5.2.3 Saxagliptin
5.2.4 Alogliptin
5.2.5 Linagliptin
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World DPP-4 Inhibitor Hypoglycemic Drugs Production by Type (2018-2029)
5.3.2 World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Type (2018-2029)
5.3.3 World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World DPP-4 Inhibitor Hypoglycemic Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World DPP-4 Inhibitor Hypoglycemic Drugs Production by Application (2018-2029)
6.3.2 World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Application (2018-2029)
6.3.3 World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.1.4 Merck DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 MSD Pharma
7.2.1 MSD Pharma Details
7.2.2 MSD Pharma Major Business
7.2.3 MSD Pharma DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.2.4 MSD Pharma DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 MSD Pharma Recent Developments/Updates
7.2.6 MSD Pharma Competitive Strengths & Weaknesses
7.3 Novartis
7.3.1 Novartis Details
7.3.2 Novartis Major Business
7.3.3 Novartis DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.3.4 Novartis DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Novartis Recent Developments/Updates
7.3.6 Novartis Competitive Strengths & Weaknesses
7.4 AstraZeneca Pharmaceuticals
7.4.1 AstraZeneca Pharmaceuticals Details
7.4.2 AstraZeneca Pharmaceuticals Major Business
7.4.3 AstraZeneca Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.4.4 AstraZeneca Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 AstraZeneca Pharmaceuticals Recent Developments/Updates
7.4.6 AstraZeneca Pharmaceuticals Competitive Strengths & Weaknesses
7.5 Takeda Pharmaceutical
7.5.1 Takeda Pharmaceutical Details
7.5.2 Takeda Pharmaceutical Major Business
7.5.3 Takeda Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.5.4 Takeda Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Takeda Pharmaceutical Recent Developments/Updates
7.5.6 Takeda Pharmaceutical Competitive Strengths & Weaknesses
7.6 Boehringer Ingelheim International
7.6.1 Boehringer Ingelheim International Details
7.6.2 Boehringer Ingelheim International Major Business
7.6.3 Boehringer Ingelheim International DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.6.4 Boehringer Ingelheim International DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Boehringer Ingelheim International Recent Developments/Updates
7.6.6 Boehringer Ingelheim International Competitive Strengths & Weaknesses
7.7 Huahai Pharmaceutical
7.7.1 Huahai Pharmaceutical Details
7.7.2 Huahai Pharmaceutical Major Business
7.7.3 Huahai Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.7.4 Huahai Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Huahai Pharmaceutical Recent Developments/Updates
7.7.6 Huahai Pharmaceutical Competitive Strengths & Weaknesses
7.8 Langnuo Pharmaceutical
7.8.1 Langnuo Pharmaceutical Details
7.8.2 Langnuo Pharmaceutical Major Business
7.8.3 Langnuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.8.4 Langnuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Langnuo Pharmaceutical Recent Developments/Updates
7.8.6 Langnuo Pharmaceutical Competitive Strengths & Weaknesses
7.9 QILU Pharmaceutical
7.9.1 QILU Pharmaceutical Details
7.9.2 QILU Pharmaceutical Major Business
7.9.3 QILU Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.9.4 QILU Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 QILU Pharmaceutical Recent Developments/Updates
7.9.6 QILU Pharmaceutical Competitive Strengths & Weaknesses
7.10 Chia Tai-Tianqing Pharmaceutical
7.10.1 Chia Tai-Tianqing Pharmaceutical Details
7.10.2 Chia Tai-Tianqing Pharmaceutical Major Business
7.10.3 Chia Tai-Tianqing Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.10.4 Chia Tai-Tianqing Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
7.10.6 Chia Tai-Tianqing Pharmaceutical Competitive Strengths & Weaknesses
7.11 Gan & Lee Pharmaceuticals
7.11.1 Gan & Lee Pharmaceuticals Details
7.11.2 Gan & Lee Pharmaceuticals Major Business
7.11.3 Gan & Lee Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.11.4 Gan & Lee Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Gan & Lee Pharmaceuticals Recent Developments/Updates
7.11.6 Gan & Lee Pharmaceuticals Competitive Strengths & Weaknesses
7.12 Kelun Pharmaceutical
7.12.1 Kelun Pharmaceutical Details
7.12.2 Kelun Pharmaceutical Major Business
7.12.3 Kelun Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.12.4 Kelun Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Kelun Pharmaceutical Recent Developments/Updates
7.12.6 Kelun Pharmaceutical Competitive Strengths & Weaknesses
7.13 YOKO Pharmaceutical
7.13.1 YOKO Pharmaceutical Details
7.13.2 YOKO Pharmaceutical Major Business
7.13.3 YOKO Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.13.4 YOKO Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 YOKO Pharmaceutical Recent Developments/Updates
7.13.6 YOKO Pharmaceutical Competitive Strengths & Weaknesses
7.14 Disainuo Pharmaceutical
7.14.1 Disainuo Pharmaceutical Details
7.14.2 Disainuo Pharmaceutical Major Business
7.14.3 Disainuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.14.4 Disainuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Disainuo Pharmaceutical Recent Developments/Updates
7.14.6 Disainuo Pharmaceutical Competitive Strengths & Weaknesses
7.15 Reyoung Pharmaceutical
7.15.1 Reyoung Pharmaceutical Details
7.15.2 Reyoung Pharmaceutical Major Business
7.15.3 Reyoung Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
7.15.4 Reyoung Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Reyoung Pharmaceutical Recent Developments/Updates
7.15.6 Reyoung Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 DPP-4 Inhibitor Hypoglycemic Drugs Industry Chain
8.2 DPP-4 Inhibitor Hypoglycemic Drugs Upstream Analysis
8.2.1 DPP-4 Inhibitor Hypoglycemic Drugs Core Raw Materials
8.2.2 Main Manufacturers of DPP-4 Inhibitor Hypoglycemic Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 DPP-4 Inhibitor Hypoglycemic Drugs Production Mode
8.6 DPP-4 Inhibitor Hypoglycemic Drugs Procurement Model
8.7 DPP-4 Inhibitor Hypoglycemic Drugs Industry Sales Model and Sales Channels
8.7.1 DPP-4 Inhibitor Hypoglycemic Drugs Sales Model
8.7.2 DPP-4 Inhibitor Hypoglycemic Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share by Region (2018-2023)
Table 5. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share by Region (2024-2029)
Table 6. World DPP-4 Inhibitor Hypoglycemic Drugs Production by Region (2018-2023) & (K Units)
Table 7. World DPP-4 Inhibitor Hypoglycemic Drugs Production by Region (2024-2029) & (K Units)
Table 8. World DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share by Region (2018-2023)
Table 9. World DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share by Region (2024-2029)
Table 10. World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. DPP-4 Inhibitor Hypoglycemic Drugs Major Market Trends
Table 13. World DPP-4 Inhibitor Hypoglycemic Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World DPP-4 Inhibitor Hypoglycemic Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World DPP-4 Inhibitor Hypoglycemic Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key DPP-4 Inhibitor Hypoglycemic Drugs Producers in 2022
Table 18. World DPP-4 Inhibitor Hypoglycemic Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key DPP-4 Inhibitor Hypoglycemic Drugs Producers in 2022
Table 20. World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global DPP-4 Inhibitor Hypoglycemic Drugs Company Evaluation Quadrant
Table 22. World DPP-4 Inhibitor Hypoglycemic Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and DPP-4 Inhibitor Hypoglycemic Drugs Production Site of Key Manufacturer
Table 24. DPP-4 Inhibitor Hypoglycemic Drugs Market: Company Product Type Footprint
Table 25. DPP-4 Inhibitor Hypoglycemic Drugs Market: Company Product Application Footprint
Table 26. DPP-4 Inhibitor Hypoglycemic Drugs Competitive Factors
Table 27. DPP-4 Inhibitor Hypoglycemic Drugs New Entrant and Capacity Expansion Plans
Table 28. DPP-4 Inhibitor Hypoglycemic Drugs Mergers & Acquisitions Activity
Table 29. United States VS China DPP-4 Inhibitor Hypoglycemic Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China DPP-4 Inhibitor Hypoglycemic Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China DPP-4 Inhibitor Hypoglycemic Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based DPP-4 Inhibitor Hypoglycemic Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share (2018-2023)
Table 37. China Based DPP-4 Inhibitor Hypoglycemic Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based DPP-4 Inhibitor Hypoglycemic Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share (2018-2023)
Table 47. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World DPP-4 Inhibitor Hypoglycemic Drugs Production by Type (2018-2023) & (K Units)
Table 49. World DPP-4 Inhibitor Hypoglycemic Drugs Production by Type (2024-2029) & (K Units)
Table 50. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World DPP-4 Inhibitor Hypoglycemic Drugs Production by Application (2018-2023) & (K Units)
Table 56. World DPP-4 Inhibitor Hypoglycemic Drugs Production by Application (2024-2029) & (K Units)
Table 57. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 64. Merck DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. MSD Pharma Basic Information, Manufacturing Base and Competitors
Table 68. MSD Pharma Major Business
Table 69. MSD Pharma DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 70. MSD Pharma DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. MSD Pharma Recent Developments/Updates
Table 72. MSD Pharma Competitive Strengths & Weaknesses
Table 73. Novartis Basic Information, Manufacturing Base and Competitors
Table 74. Novartis Major Business
Table 75. Novartis DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 76. Novartis DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Novartis Recent Developments/Updates
Table 78. Novartis Competitive Strengths & Weaknesses
Table 79. AstraZeneca Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. AstraZeneca Pharmaceuticals Major Business
Table 81. AstraZeneca Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 82. AstraZeneca Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. AstraZeneca Pharmaceuticals Recent Developments/Updates
Table 84. AstraZeneca Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 86. Takeda Pharmaceutical Major Business
Table 87. Takeda Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 88. Takeda Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Takeda Pharmaceutical Recent Developments/Updates
Table 90. Takeda Pharmaceutical Competitive Strengths & Weaknesses
Table 91. Boehringer Ingelheim International Basic Information, Manufacturing Base and Competitors
Table 92. Boehringer Ingelheim International Major Business
Table 93. Boehringer Ingelheim International DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 94. Boehringer Ingelheim International DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Boehringer Ingelheim International Recent Developments/Updates
Table 96. Boehringer Ingelheim International Competitive Strengths & Weaknesses
Table 97. Huahai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. Huahai Pharmaceutical Major Business
Table 99. Huahai Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 100. Huahai Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Huahai Pharmaceutical Recent Developments/Updates
Table 102. Huahai Pharmaceutical Competitive Strengths & Weaknesses
Table 103. Langnuo Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Langnuo Pharmaceutical Major Business
Table 105. Langnuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 106. Langnuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Langnuo Pharmaceutical Recent Developments/Updates
Table 108. Langnuo Pharmaceutical Competitive Strengths & Weaknesses
Table 109. QILU Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 110. QILU Pharmaceutical Major Business
Table 111. QILU Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 112. QILU Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. QILU Pharmaceutical Recent Developments/Updates
Table 114. QILU Pharmaceutical Competitive Strengths & Weaknesses
Table 115. Chia Tai-Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Chia Tai-Tianqing Pharmaceutical Major Business
Table 117. Chia Tai-Tianqing Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 118. Chia Tai-Tianqing Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
Table 120. Chia Tai-Tianqing Pharmaceutical Competitive Strengths & Weaknesses
Table 121. Gan & Lee Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 122. Gan & Lee Pharmaceuticals Major Business
Table 123. Gan & Lee Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 124. Gan & Lee Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Gan & Lee Pharmaceuticals Recent Developments/Updates
Table 126. Gan & Lee Pharmaceuticals Competitive Strengths & Weaknesses
Table 127. Kelun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 128. Kelun Pharmaceutical Major Business
Table 129. Kelun Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 130. Kelun Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Kelun Pharmaceutical Recent Developments/Updates
Table 132. Kelun Pharmaceutical Competitive Strengths & Weaknesses
Table 133. YOKO Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 134. YOKO Pharmaceutical Major Business
Table 135. YOKO Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 136. YOKO Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. YOKO Pharmaceutical Recent Developments/Updates
Table 138. YOKO Pharmaceutical Competitive Strengths & Weaknesses
Table 139. Disainuo Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 140. Disainuo Pharmaceutical Major Business
Table 141. Disainuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 142. Disainuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Disainuo Pharmaceutical Recent Developments/Updates
Table 144. Reyoung Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 145. Reyoung Pharmaceutical Major Business
Table 146. Reyoung Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 147. Reyoung Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of DPP-4 Inhibitor Hypoglycemic Drugs Upstream (Raw Materials)
Table 149. DPP-4 Inhibitor Hypoglycemic Drugs Typical Customers
Table 150. DPP-4 Inhibitor Hypoglycemic Drugs Typical Distributors
Table 1. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share by Region (2018-2023)
Table 5. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share by Region (2024-2029)
Table 6. World DPP-4 Inhibitor Hypoglycemic Drugs Production by Region (2018-2023) & (K Units)
Table 7. World DPP-4 Inhibitor Hypoglycemic Drugs Production by Region (2024-2029) & (K Units)
Table 8. World DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share by Region (2018-2023)
Table 9. World DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share by Region (2024-2029)
Table 10. World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. DPP-4 Inhibitor Hypoglycemic Drugs Major Market Trends
Table 13. World DPP-4 Inhibitor Hypoglycemic Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World DPP-4 Inhibitor Hypoglycemic Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World DPP-4 Inhibitor Hypoglycemic Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key DPP-4 Inhibitor Hypoglycemic Drugs Producers in 2022
Table 18. World DPP-4 Inhibitor Hypoglycemic Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key DPP-4 Inhibitor Hypoglycemic Drugs Producers in 2022
Table 20. World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global DPP-4 Inhibitor Hypoglycemic Drugs Company Evaluation Quadrant
Table 22. World DPP-4 Inhibitor Hypoglycemic Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and DPP-4 Inhibitor Hypoglycemic Drugs Production Site of Key Manufacturer
Table 24. DPP-4 Inhibitor Hypoglycemic Drugs Market: Company Product Type Footprint
Table 25. DPP-4 Inhibitor Hypoglycemic Drugs Market: Company Product Application Footprint
Table 26. DPP-4 Inhibitor Hypoglycemic Drugs Competitive Factors
Table 27. DPP-4 Inhibitor Hypoglycemic Drugs New Entrant and Capacity Expansion Plans
Table 28. DPP-4 Inhibitor Hypoglycemic Drugs Mergers & Acquisitions Activity
Table 29. United States VS China DPP-4 Inhibitor Hypoglycemic Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China DPP-4 Inhibitor Hypoglycemic Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China DPP-4 Inhibitor Hypoglycemic Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based DPP-4 Inhibitor Hypoglycemic Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share (2018-2023)
Table 37. China Based DPP-4 Inhibitor Hypoglycemic Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based DPP-4 Inhibitor Hypoglycemic Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share (2018-2023)
Table 47. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World DPP-4 Inhibitor Hypoglycemic Drugs Production by Type (2018-2023) & (K Units)
Table 49. World DPP-4 Inhibitor Hypoglycemic Drugs Production by Type (2024-2029) & (K Units)
Table 50. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World DPP-4 Inhibitor Hypoglycemic Drugs Production by Application (2018-2023) & (K Units)
Table 56. World DPP-4 Inhibitor Hypoglycemic Drugs Production by Application (2024-2029) & (K Units)
Table 57. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 64. Merck DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. MSD Pharma Basic Information, Manufacturing Base and Competitors
Table 68. MSD Pharma Major Business
Table 69. MSD Pharma DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 70. MSD Pharma DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. MSD Pharma Recent Developments/Updates
Table 72. MSD Pharma Competitive Strengths & Weaknesses
Table 73. Novartis Basic Information, Manufacturing Base and Competitors
Table 74. Novartis Major Business
Table 75. Novartis DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 76. Novartis DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Novartis Recent Developments/Updates
Table 78. Novartis Competitive Strengths & Weaknesses
Table 79. AstraZeneca Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. AstraZeneca Pharmaceuticals Major Business
Table 81. AstraZeneca Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 82. AstraZeneca Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. AstraZeneca Pharmaceuticals Recent Developments/Updates
Table 84. AstraZeneca Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 86. Takeda Pharmaceutical Major Business
Table 87. Takeda Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 88. Takeda Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Takeda Pharmaceutical Recent Developments/Updates
Table 90. Takeda Pharmaceutical Competitive Strengths & Weaknesses
Table 91. Boehringer Ingelheim International Basic Information, Manufacturing Base and Competitors
Table 92. Boehringer Ingelheim International Major Business
Table 93. Boehringer Ingelheim International DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 94. Boehringer Ingelheim International DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Boehringer Ingelheim International Recent Developments/Updates
Table 96. Boehringer Ingelheim International Competitive Strengths & Weaknesses
Table 97. Huahai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. Huahai Pharmaceutical Major Business
Table 99. Huahai Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 100. Huahai Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Huahai Pharmaceutical Recent Developments/Updates
Table 102. Huahai Pharmaceutical Competitive Strengths & Weaknesses
Table 103. Langnuo Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Langnuo Pharmaceutical Major Business
Table 105. Langnuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 106. Langnuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Langnuo Pharmaceutical Recent Developments/Updates
Table 108. Langnuo Pharmaceutical Competitive Strengths & Weaknesses
Table 109. QILU Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 110. QILU Pharmaceutical Major Business
Table 111. QILU Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 112. QILU Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. QILU Pharmaceutical Recent Developments/Updates
Table 114. QILU Pharmaceutical Competitive Strengths & Weaknesses
Table 115. Chia Tai-Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Chia Tai-Tianqing Pharmaceutical Major Business
Table 117. Chia Tai-Tianqing Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 118. Chia Tai-Tianqing Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
Table 120. Chia Tai-Tianqing Pharmaceutical Competitive Strengths & Weaknesses
Table 121. Gan & Lee Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 122. Gan & Lee Pharmaceuticals Major Business
Table 123. Gan & Lee Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 124. Gan & Lee Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Gan & Lee Pharmaceuticals Recent Developments/Updates
Table 126. Gan & Lee Pharmaceuticals Competitive Strengths & Weaknesses
Table 127. Kelun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 128. Kelun Pharmaceutical Major Business
Table 129. Kelun Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 130. Kelun Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Kelun Pharmaceutical Recent Developments/Updates
Table 132. Kelun Pharmaceutical Competitive Strengths & Weaknesses
Table 133. YOKO Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 134. YOKO Pharmaceutical Major Business
Table 135. YOKO Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 136. YOKO Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. YOKO Pharmaceutical Recent Developments/Updates
Table 138. YOKO Pharmaceutical Competitive Strengths & Weaknesses
Table 139. Disainuo Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 140. Disainuo Pharmaceutical Major Business
Table 141. Disainuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 142. Disainuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Disainuo Pharmaceutical Recent Developments/Updates
Table 144. Reyoung Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 145. Reyoung Pharmaceutical Major Business
Table 146. Reyoung Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product and Services
Table 147. Reyoung Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of DPP-4 Inhibitor Hypoglycemic Drugs Upstream (Raw Materials)
Table 149. DPP-4 Inhibitor Hypoglycemic Drugs Typical Customers
Table 150. DPP-4 Inhibitor Hypoglycemic Drugs Typical Distributors
LIST OF FIGURES
Figure 1. DPP-4 Inhibitor Hypoglycemic Drugs Picture
Figure 2. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2029) & (K Units)
Figure 5. World DPP-4 Inhibitor Hypoglycemic Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share by Region (2018-2029)
Figure 8. North America DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2029) & (K Units)
Figure 9. Europe DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2029) & (K Units)
Figure 10. China DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2029) & (K Units)
Figure 11. Japan DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2029) & (K Units)
Figure 12. DPP-4 Inhibitor Hypoglycemic Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029) & (K Units)
Figure 15. World DPP-4 Inhibitor Hypoglycemic Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029) & (K Units)
Figure 17. China DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029) & (K Units)
Figure 22. India DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of DPP-4 Inhibitor Hypoglycemic Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for DPP-4 Inhibitor Hypoglycemic Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for DPP-4 Inhibitor Hypoglycemic Drugs Markets in 2022
Figure 26. United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share 2022
Figure 30. China Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share 2022
Figure 32. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share by Type in 2022
Figure 34. Sitagliptin
Figure 35. Vildagliptin
Figure 36. Saxagliptin
Figure 37. Alogliptin
Figure 38. Linagliptin
Figure 39. Others
Figure 40. World DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share by Type (2018-2029)
Figure 41. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share by Type (2018-2029)
Figure 42. World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 43. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 44. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share by Application in 2022
Figure 45. Hospital
Figure 46. Clinic
Figure 47. World DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share by Application (2018-2029)
Figure 48. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share by Application (2018-2029)
Figure 49. World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. DPP-4 Inhibitor Hypoglycemic Drugs Industry Chain
Figure 51. DPP-4 Inhibitor Hypoglycemic Drugs Procurement Model
Figure 52. DPP-4 Inhibitor Hypoglycemic Drugs Sales Model
Figure 53. DPP-4 Inhibitor Hypoglycemic Drugs Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. DPP-4 Inhibitor Hypoglycemic Drugs Picture
Figure 2. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2029) & (K Units)
Figure 5. World DPP-4 Inhibitor Hypoglycemic Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share by Region (2018-2029)
Figure 8. North America DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2029) & (K Units)
Figure 9. Europe DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2029) & (K Units)
Figure 10. China DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2029) & (K Units)
Figure 11. Japan DPP-4 Inhibitor Hypoglycemic Drugs Production (2018-2029) & (K Units)
Figure 12. DPP-4 Inhibitor Hypoglycemic Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029) & (K Units)
Figure 15. World DPP-4 Inhibitor Hypoglycemic Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029) & (K Units)
Figure 17. China DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029) & (K Units)
Figure 22. India DPP-4 Inhibitor Hypoglycemic Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of DPP-4 Inhibitor Hypoglycemic Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for DPP-4 Inhibitor Hypoglycemic Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for DPP-4 Inhibitor Hypoglycemic Drugs Markets in 2022
Figure 26. United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: DPP-4 Inhibitor Hypoglycemic Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share 2022
Figure 30. China Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share 2022
Figure 32. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share by Type in 2022
Figure 34. Sitagliptin
Figure 35. Vildagliptin
Figure 36. Saxagliptin
Figure 37. Alogliptin
Figure 38. Linagliptin
Figure 39. Others
Figure 40. World DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share by Type (2018-2029)
Figure 41. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share by Type (2018-2029)
Figure 42. World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 43. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 44. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share by Application in 2022
Figure 45. Hospital
Figure 46. Clinic
Figure 47. World DPP-4 Inhibitor Hypoglycemic Drugs Production Market Share by Application (2018-2029)
Figure 48. World DPP-4 Inhibitor Hypoglycemic Drugs Production Value Market Share by Application (2018-2029)
Figure 49. World DPP-4 Inhibitor Hypoglycemic Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. DPP-4 Inhibitor Hypoglycemic Drugs Industry Chain
Figure 51. DPP-4 Inhibitor Hypoglycemic Drugs Procurement Model
Figure 52. DPP-4 Inhibitor Hypoglycemic Drugs Sales Model
Figure 53. DPP-4 Inhibitor Hypoglycemic Drugs Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
